About 600 reports

Abstract: - Global Calcium Channel Blockers Market to Reach $18.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Calcium Channel Blockers estimated at US$13.3 Billion in the year 2020, is projected to reach a revised size of US$18.9 Billion by 2027, growing at aCAGR of 5.2% over the period 2020-2027....

  • Calcium Channel Blocker
  • World
  • China
  • United States

Calcium Channel Blocker Market Report Overview Calcium Channel Blocker market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Calcium Channel Blocker market types and applications. It is a focused study on Calcium Channel Blocker market space...

  • Calcium Channel Blocker
  • World
  • Health Provider Density

Calcium Channel Blocker market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Calcium Channel Blocker Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Calcium Channel Blocker types, applications. Further,...

  • Calcium Channel Blocker
  • World

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021 Summary Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance...

  • Calcium Channel Blocker
  • World

Abstract: - Global Angina Pectoris Drugs Market to Reach $14.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Angina Pectoris Drugs estimated at US$10 Billion in the year 2020, is projected to reach a revised size of US$14.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027....

  • Angina
  • Calcium Channel Blocker
  • World
  • China
  • United States

Abstract: - Global Acute Heart Failure (AHF) Therapeutics Market to Reach $1.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Heart Failure (AHF) Therapeutics estimated at US$372.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of...

  • Therapy
  • Heart Failure
  • World
  • China
  • United States

Abstract: - Global Chronic Kidney Disease (CKD) Drugs Market to Reach $15.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Chronic Kidney Disease (CKD) Drugs estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 1.9% over...

  • Chronic Disease
  • World
  • China
  • United States

Chart ##: Calcium Channel Blocker Sales Volume and Market Share (Million yuan/Percent)

  • Hypertension
  • China
  • Industrial Production
  • Labour Force

The global ischemic heart disease (IHD) drugs market is expected to exhibit strong growth during 2021-2026. Ischemic heart disease (IHD), also known as coronary heart disease, is a condition that damages the heart muscle by interrupting the oxygen and blood supply. It involves molecular changes in the blood vessels...

  • Cardiovascular Disease
  • World

The global pulmonary arterial hypertension (PAH) drugs market reached a value of US$ 6.8 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 7.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Hypertension
  • World
  • Medical Technology Density

Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Antihypertensive
  • In-Store Retail
  • Pharmacy
  • Calcium Channel Blocker
  • World
  • APAC
  • Europe

Overview "Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent Calcium Channel Blockers pipeline landscape is provided, which includes the topic...

  • Calcium Channel Blocker
  • World
  • Health Expenditure

Abstract: - Global Anti-Hypertensive Drugs Market to Reach $33.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Hypertensive Drugs estimated at US$32.7 Billion in the year 2020, is projected to reach a revised size of US$33.2 Billion by 2027, growing at a CAGR of 0.2% over the analysis period...

  • Antihypertensive
  • World
  • China
  • United States

Abstract: - Global Scleroderma Diagnostics and Therapeutics Market to Reach $4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Scleroderma Diagnostics and Therapeutics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at aCAGR of 10.3%...

  • Therapy
  • Dermatological Condition
  • Autoimmune Disease
  • Diagnostics
  • World
  • China
  • United States

Overview "Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Voltage-Dependent T-Type Calcium Channel Blockers pipeline landscape is provided, which includes...

  • Calcium Channel Blocker
  • World
  • Health Expenditure

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, and Bayer AG. The global anti-hypertensive drugs market...

  • Antihypertensive
  • World
  • APAC
  • Cause-Specific Mortality Rate

Treatment includes sildenafil, prostanoids and calcium channel blockers.

  • Drug Development
  • Hypertension
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

Supportive treatment includes diuretics, calcium channel blockers, beta blockers, angiotensin receptor blockers and angiotensin converting enzyme (ACE) inhibitors.

  • Therapy
  • World
  • Pharmaceutical Registrations
  • Drug Approval

Treatment includes sildenafil, prostanoids and calcium channel blockers.

  • Hypertension
  • South Africa
  • Drug Approval
  • Cause-Specific Mortality Rate

Antihypertensive Drugs Market – Scope of the Report This report on the global antihypertensive drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.The report provides the overall...

  • Antihypertensive
  • World

Atherosclerosis Drugs Market – Scope of the Report This report on the global atherosclerosis drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027.The report provides the overall market...

  • Cardiovascular Disease
  • World

Supportive treatment includes diuretics, calcium channel blockers, beta blockers, angiotensin receptor blockers and angiotensin converting enzyme (ACE) inhibitors.

  • Therapy
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations
  • Drug Approval

KEY FINDINGS During the forecast period from 2019 to 2028, the global antihypertensive drugs market is estimated to grow with a CAGR of 3.21%. A surge in the prevalence of hypertension and a rise in awareness of complications related to hypertension, as well as an increase in the geriatric population and sedentary lifestyle,...

  • Hypertension
  • Antihypertensive
  • World
  • North America

Calcium Channel Blocker

  • Hypertension
  • China
  • Industrial Production
  • Labour Force

Treatment includes beta blockers, calcium channel blockers and blood thinners.

  • Cardiovascular Disease
  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Interest Payments Paid By Central Government

Report Scope: The current report offers a detailed analysis of the antihypertensive drug market.The study includes a discussion of antihypertensive drugs prescribed for lowering the high blood pressure and for the treatment of pulmonary arterial hypertension (PAH). The report excludes drugs used in the treatment...

  • Antihypertensive
  • World
  • Europe
  • North America
  • China
  • Japan
  • Middle East
  • United States
  • APAC
  • Italy
  • United Kingdom
  • Canada
  • Spain
  • France
  • Germany
  • India
  • South America
  • Russia
  • Mexico
  • Africa

Treatm ent includes beta bl ockers, calcium channel blockers and blood thinners.

  • Cardiovascular Disease
  • World
  • Pharmaceutical Registrations
  • Interest Payments Paid By Central Government

Table ##: Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification in 2020 (Percent)

  • Hypertension
  • China
  • Employment Costs
  • Fuel Demand

Treatment includes beta blockers, calcium channel blockers and blood thinners.

  • Cardiovascular Disease
  • World
  • Pharmaceutical Registrations
  • Interest Payments Paid By Central Government

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Calcium Channel Blocker
  • Pharmaceutical
  • World